A detailed history of Pro Share Advisors LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 30,326 shares of GH stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,326
Previous 23,441 29.37%
Holding current value
$1.06 Million
Previous $676,000 2.81%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$22.3 - $36.29 $153,535 - $249,856
6,885 Added 29.37%
30,326 $695,000
Q2 2024

Aug 13, 2024

SELL
$16.07 - $31.84 $94,427 - $187,091
-5,876 Reduced 20.04%
23,441 $676,000
Q1 2024

May 08, 2024

BUY
$17.13 - $26.91 $43,133 - $67,759
2,518 Added 9.4%
29,317 $604,000
Q4 2023

Feb 14, 2024

BUY
$21.58 - $29.5 $89,794 - $122,749
4,161 Added 18.38%
26,799 $724,000
Q3 2023

Nov 13, 2023

BUY
$25.8 - $39.97 $7,740 - $11,991
300 Added 1.34%
22,638 $670,000
Q2 2023

Aug 10, 2023

BUY
$20.94 - $38.01 $467,757 - $849,067
22,338 New
22,338 $799,000
Q4 2022

Feb 02, 2023

SELL
$25.44 - $59.78 $5,037 - $11,836
-198 Reduced 1.94%
10,026 $272,000
Q3 2022

Nov 04, 2022

BUY
$43.66 - $61.0 $26,938 - $37,637
617 Added 6.42%
10,224 $551,000
Q2 2022

Aug 01, 2022

SELL
$28.82 - $77.35 $93,809 - $251,774
-3,255 Reduced 25.31%
9,607 $387,000
Q1 2022

May 10, 2022

SELL
$48.25 - $100.49 $193,193 - $402,361
-4,004 Reduced 23.74%
12,862 $852,000
Q4 2021

Feb 08, 2022

SELL
$88.71 - $120.43 $636,316 - $863,844
-7,173 Reduced 29.84%
16,866 $1.69 Million
Q3 2021

Nov 12, 2021

BUY
$98.77 - $132.17 $271,024 - $362,674
2,744 Added 12.89%
24,039 $3.01 Million
Q2 2021

Aug 13, 2021

BUY
$109.77 - $165.68 $636,226 - $960,281
5,796 Added 37.4%
21,295 $2.65 Million
Q1 2021

May 14, 2021

SELL
$127.04 - $179.1 $185,097 - $260,948
-1,457 Reduced 8.59%
15,499 $2.37 Million
Q4 2020

Feb 09, 2021

SELL
$99.96 - $135.93 $40,783 - $55,459
-408 Reduced 2.35%
16,956 $2.19 Million
Q3 2020

Nov 13, 2020

BUY
$80.32 - $111.8 $113,251 - $157,638
1,410 Added 8.84%
17,364 $1.94 Million
Q2 2020

Aug 03, 2020

BUY
$60.49 - $97.5 $137,796 - $222,105
2,278 Added 16.66%
15,954 $1.29 Million
Q1 2020

May 15, 2020

SELL
$59.04 - $88.81 $448,408 - $674,511
-7,595 Reduced 35.71%
13,676 $952,000
Q4 2019

Feb 12, 2020

BUY
$59.49 - $82.78 $1.27 Million - $1.76 Million
21,271 New
21,271 $1.66 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.59B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.